Vitestro today launched its Aletta autonomous robotic phlebotomy device (ARPD) that performs automated blood draws.

Vitestro, a pioneer in medical robotics, proudly reveals the name of its autonomous blood drawing device: Aletta™, the first ...

Vitestro has unveiled Aletta, claimed to be the “world's first” Autonomous Robotic Phlebotomy Device (ARPD), designed for ...

Takeda and Protagonist Therapeutics have reported positive topline outcomes from their Phase III VERIFY trial of rusfertide ...

Protagonist Therapeutics notches a milestone in its pact with Takeda for rusfertide. New data show that many patients with a ...

Hastings Public Schools Foundation, Mary Lanning Healthcare Foundation, and Central Community College have all agreed to ...

Vitestro has introduced Aletta, and they claim it's the world's first autonomous robotic phlebotomy device, marking a ...

This phlebotomy training programme in adult venepuncture will incorporate academic learning in addition to practical application. The period of training lasts up to 3 months, leading to an assessment ...

DocGo, a mobile health services provider, has acquired PTI Health, a company specialising in mobile lab collection and phlebotomy services in the mid-Atlantic region. This move aims to address the ...

Among phlebotomy-dependent patients with polycythemia vera, the addition of rusfertide to standard-of-care treatment resulted ...

Officials with the Office of Workforce Development and Community Education at Missouri State University-West Plains (MSU-WP) ...